Ferring Pharmaceuticals
Ferring Pharmaceuticals (Switzerland) is linked to 5 FDA-registered manufacturing sites. 14 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Ferring Pharmaceuticals: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/ferring-pharmaceuticals
Overview
Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. Specializing in reproductive health, urology, gastroenterology, endocrinology, and orthopaedics, Ferring has extensive expertise in peptide-based drugs and biotechnology. The company is privately owned and operates in over 60 countries across the globe.
Therapeutic areas
Registered manufacturing sites (5)
Physical sites registered with the US FDA and resolved to Ferring Pharmaceuticals, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.
- Bio-Technology General (Israel) Ltd.Kiryat Malachi, Israel · API manufactureSite GMP match
- Ferring Controlled Therapeutics Ltd.Glasgow, United Kingdom · Analytical testing · LabellingSite GMP match
- Ferring GmbHKiel, Germany · Analytical testing · LabellingSite GMP match
- Ferring Microbiome Inc.Saint Paul, United States · API manufacture
- Instituto Massone S.A.Buenos Aires, Argentina · API manufactureSite GMP match
FDA compliance signals
14 FDA enforcement records linked to this company.
- recall — Class II2023-07-05
cGMP deviations: potential for Microbial Contamination of Non-Sterile Products
- recall — Class II2021-04-07
Defective Delivery System: customer complaints concerning the injector pen breaking apart and disintegrating into pieces.
- recall — Class II2021-04-07
Defective Delivery System: customer complaints concerning the injector pen breaking apart and disintegrating into pieces.
- recall — Class III2021-03-17
Failed pH specifications: Out of Specification pH results for 0.9% Sodium Chloride, USP
- recall — Class I2020-08-26
Superpotent Drug
- recall — Class I2020-08-26
Superpotent Drug
- recall — Class I2020-08-26
Superpotent Drug
- recall — Class III2015-10-21
Subpotent Drug
- recall — Class III2014-07-16
Discoloration; due to prolonged heat exposure.
- recall — Class II2014-06-25
Chemical Contamination: TEV-TROPIN [somatropin (rDNA origin) for injection] may contain silicone oil due to leakage of a leaking line during the freeze-drying process.
- recall — Class III2013-04-10
Labeling: Label Mix-up: Units of Lot 201131320087 are packaged in cartons labelled for Needle-Free Head B, but contaiin Needle-Free Head A
- recall — Class III2012-12-12
Labeling; incorrect or missing insert; Warnings portion of the Package Insert is missing the warning statement: Anaphylaxis has been reported with urinary-derived hCG products.
- 4832011-09-20
Late submission of 15-day report
- 4832011-09-20
Late submission of quarterly safety reports
Is this Ferring Pharmaceuticals?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.